National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 50349-50350 [2024-13022]

Download as PDF Federal Register / Vol. 89, No. 115 / Thursday, June 13, 2024 / Notices 6021, Bethesda, MD 20892, (301) 496–9350, sheila.pirooznia@nih.gov. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; Psychedelics Treatment Research in Substance Use Disorder. Date: July 16, 2024. Time: 11:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, National Institute on Drug Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Soyoun Cho, Ph.D., Scientific Review Officer, Scientific Review Branch, Division of Extramural Research, National Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue, MSC 6021, Bethesda, MD 20892, (301) 594–9460, Soyoun.cho@nih.gov. Contact Person: Brian Stefan Wolff, Ph.D., Scientific Review Officer, Scientific Review Branch, Division of Extramural Research, National Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue, MSC 6021, Bethesda, MD 20892, (301) 480–1448, brian.wolff@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug Abuse Scientist Development Award for Clinicians, Scientist Development Awards, and Research Scientist Awards; 93.278, Drug Abuse National Research Service Awards for Research Training; 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS) Dated: June 7, 2024. Lauren A. Fleck, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–12990 Filed 6–12–24; 8:45 am] lotter on DSK11XQN23PROD with NOTICES1 Office of the Secretary; Notice of Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Interagency Pain Research Coordinating Committee. The meeting will be held as a virtual meeting and will be open to the public as indicated below. Individuals who plan to view the virtual meeting and need special assistance or other reasonable accommodations to view the meeting, should notify the Contact Person listed below in advance of the meeting. The meeting can be accessed from the NIH Videocast at the following link: https://videocast.nih.gov/. 19:28 Jun 12, 2024 Jkt 262001 Dated: June 10, 2024. Lauren A. Fleck, Program Analyst, Office of Federal Advisory Committee Policy. National Institutes of Health [FR Doc. 2024–13023 Filed 6–12–24; 8:45 am] BILLING CODE 4140–01–P National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting National Institutes of Health VerDate Sep<11>2014 Date: July 9, 2024. Time: 11:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G31B, Rockville, MD 20852 (Video Assisted Meeting). Contact Person: James T. Snyder, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G31B, Rockville, MD 20852, (240) 669–5060, james.snyder@ nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) National Institutes of Health DEPARTMENT OF HEALTH AND HUMAN SERVICES Name of Committee: Interagency Pain Research Coordinating Committee. Date: July 10, 2024. Time: 9:30 a.m. to 12:00 p.m. Eastern Time (ET). Agenda: The meeting will cover committee business items and Interagency Pain Research Coordinating Committee member updates. Items discussed will include updates on Helping to End Addiction Longterm and Federal Pain Research Strategy research progress. Webcast Live: https://videocast.nih.gov/. Deadline: Submission of intent to submit written/electronic statement for comments: Monday, July 3, 2024, by 5:00 p.m. ET. Place: National Institutes of Health Building 31, 31 Center Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Linda L. Porter, Ph.D., Director, Office of Pain Policy and Planning, Office of the Director, National Institute of Neurological Disorders and Stroke, NIH, 31 Center Drive, Room 8A31, Bethesda, MD 20892, Phone: (301) 451–4460, Email: Linda.Porter@nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Visit the IPRCC website for more information: https://iprcc.nih.gov. Agenda and any additional information for the meeting will be posted when available. DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4140–01–P 50349 Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed). PO 00000 Frm 00097 Fmt 4703 Sfmt 4703 Dated: June 10, 2024. Lauren A. Fleck, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–13024 Filed 6–12–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed). Date: July 25, 2024. Time: 8:30 a.m. to 1:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G22, Rockville, MD 20852 (Video Assisted Meeting). Contact Person: Michael M. Opata, Ph.D., Scientific Review Officer, Scientific Review E:\FR\FM\13JNN1.SGM 13JNN1 50350 Federal Register / Vol. 89, No. 115 / Thursday, June 13, 2024 / Notices Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G22, Rockville, MD 20852, 240–627–3319, michael.opata@ nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: June 10, 2024. Lauren A. Fleck, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–13022 Filed 6–12–24; 8:45 am] BILLING CODE 4140–01–P ADVISORY COUNCIL ON HISTORIC PRESERVATION Notice of Issuance of the Department of the Army Program Comment for the Preservation of Pre-1919 Historic Army Housing, Associated Buildings and Structures, and Landscape Features Advisory Council on Historic Preservation. ACTION: Notice of issuance of the Department of the Army Program Comment for the Preservation of Pre1919 Historic Army Housing, Associated Buildings and Structures, and Landscape Features. AGENCY: The Advisory Council on Historic Preservation has issued a program comment for the U.S. Department of the Army that sets forth the way in which the Army complies with section 106 of the National Historic Preservation Act for its inventory of housing constructed prior to 1919. Management actions covered by the Program Comment include maintenance, repair, rehabilitation, abatement of hazardous materials, mothballing, lease, transfer, and conveyance. SUMMARY: The Program Comment went into effect on May 17, 2024. ADDRESSES: Address any questions concerning the Program Comment to Lauren Cooper, Office of Federal Agency Programs, Advisory Council on Historic Preservation, 401 F Street NW, Suite 308, Washington, DC 20001. FOR FURTHER INFORMATION CONTACT: Lauren Cooper, ACHP Army Liaison, (202) 517–0213, lcooper@achp.gov. SUPPLEMENTARY INFORMATION: Section 106 of the National Historic Preservation Act, 54 U.S.C. 306108 (section 106), requires federal agencies to consider the effects of projects they carry out, license, or assist lotter on DSK11XQN23PROD with NOTICES1 DATES: VerDate Sep<11>2014 19:28 Jun 12, 2024 Jkt 262001 (undertakings) on historic properties and to provide the Advisory Council on Historic Preservation (ACHP) a reasonable opportunity to comment with regard to such undertakings. The ACHP has issued the regulations that set forth the process through which federal agencies comply with these duties. Those regulations are codified under 36 CFR part 800 (section 106 regulations). Under Section 800.14(e) of those regulations, agencies can request the ACHP to provide a ‘‘program comment’’ on a particular category of undertakings in lieu of conducting individual reviews on a case-by-case basis, as set forth in 36 CFR 800.4 through 800.7. An agency can meet its section 106 responsibilities with regard to the effects of those undertakings by taking into account an applicable program comment and following the steps set forth in that comment. The U.S. Department of the Army (Army) sought a program comment for undertakings related to its inventory of approximately 865 housing units constructed prior to 1919, many of which are National Historic Landmarks. Management actions covered by the Program Comment include maintenance, repair, rehabilitation, abatement of hazardous materials, mothballing, lease, transfer, and conveyance, and the Program Comment allows the use of modern readily available industry standard building materials and methods in the implementation of management actions. The ACHP issued the Program Comment for the Preservation of Pre1919 Historic Army Housing, Associated Buildings and Structures, and Landscape Features on May 17, 2024. The section 106 regulations require that such program comments be published in the Federal Register. I. Need for the Program Comment The need for this Program Comment is based on the Army’s obligation to provide safe, healthy, quality housing to Soldiers and their families, and the unique challenges the Army has in managing NHPA section 106 compliance for its large and growing inventory of historic housing. Housing and associated living conditions are critical factors for military families. A direct connection exists between poor housing conditions and military readiness. In 2019, the Secretary of the Army declared an Army Housing Crisis due primarily to widespread deficiencies and significant quality of life, health, and safety issues affecting military families living in historic Army housing. To address the Army Housing Crisis and meet its housing obligations to PO 00000 Frm 00098 Fmt 4703 Sfmt 4703 military families, the Army must quickly and efficiently implement management actions to improve conditions in housing constructed before 1919. The section 106 project-byproject review process under existing installation-level Programmatic Agreements (PAs) contributes to delays in completing historic housing maintenance, repairs, and improvements needed for the transition in occupancy. Those delays directly impact the ability of reassigned military families to move into and occupy historic housing. The compliance process efficiencies created by the Program Comment allows the Army to quickly and efficiently address the health and safety risks from certain hazardous historic building materials, ensure cost efficient, effective, and consistent management of the overall inventory, and implement climate adaptations and use modern resilient materials. II. Pre-1919 Housing and the Program Comment The Army owns, operates, and manages the largest inventory of historic housing in the federal government with over 30,000 historic homes currently over 50 years old and subject to NHPA section 106 compliance. Approximately 867 of these historic units were constructed prior to 1919, and over 70% of these pre-1919 units have been designated as National Historic Landmarks. The Army’s inventory of pre-1919 housing is located at 19 installations in 13 states and the District of Columbia. The design and construction of the vast majority of Army pre-1919 housing follows standardized plans developed by the Army Quartermaster Corps. These standardized plans reflected prevailing civilian architectural designs, construction techniques, and community planning trends of the time, with certain regional style variations and use of locally available materials. The resulting architectural styles of pre1919 Army homes include Federal, Gothic Revival, Greek Revival, Italianate, Romanesque, Queen Anne, Colonial Revival, Spanish Revival, and Craftsman. These houses have been continuously occupied by Army families for 100 to 200 years and are actively used military assets. The intent of the Program Comment is to provide the Army with NHPA section 106 compliance for repetitive, recurring property management actions on all privatized and non-privatized Army housing, associated buildings and structures, and landscape features constructed before 1919. The property E:\FR\FM\13JNN1.SGM 13JNN1

Agencies

[Federal Register Volume 89, Number 115 (Thursday, June 13, 2024)]
[Notices]
[Pages 50349-50350]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-13022]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Global Infectious Disease Research 
Administration Development Award for Low-and Middle-Income Country 
Institutions (G11 Clinical Trial Not Allowed).
    Date: July 25, 2024.
    Time: 8:30 a.m. to 1:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G22, 
Rockville, MD 20852 (Video Assisted Meeting).
    Contact Person: Michael M. Opata, Ph.D., Scientific Review 
Officer, Scientific Review

[[Page 50350]]

Program, Division of Extramural Activities, National Institute of 
Allergy and Infectious Diseases, National Institutes of Health, 5601 
Fishers Lane, Room 3G22, Rockville, MD 20852, 240-627-3319, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: June 10, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-13022 Filed 6-12-24; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.